You can buy or sell SNOA and other stocks, options, ETFs, and crypto commission-free!
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Read More Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.
52 Week High
52 Week Low
Markets InsiderMar 12
Sonoma Pharmaceuticals Announces Substantial Cost-Cutting Measures
PETALUMA, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Specialty pharmaceutical company Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), today announced substantial cost-cutting measures, including reductions to the company’s workforce and management. The measures come on the heels of Sonoma’s highest revenue quarter ended December 31, 2018. Total revenues were $5.3 million in the quarter ended December 31, 2018, the highest in company history, an increase of 9% compared to the quarter ended December 31, 2017,...
Simply Wall StMar 8
Easy Come, Easy Go: How Sonoma Pharmaceuticals (NASDAQ:SNOA) Shareholders Torched 96% Of Their Cash
While it may not be enough for some shareholders, we think it is good to see the Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) share price up 23% in a single quarter. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. In fact, the share price has tumbled down a mountain to land 96% lower after that period. While the recent increase might be a green shoot, we’re certainly hesitant to rejoice. The million dollar question is whether the company can justify a long term recovery. While...
Expected Jun 13, After Hours